Histogen, Inc. engages in the development of potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function. It focuses on Human Multipotent Cell Conditioned Media, Human Extracellular Matrix, and Hair Stimulating Complex. The company was founded by Steven J. Mento and Gail K. Naughton on July 13, 2005 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Histogen Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Histogen Inc market cap is $1.5M.
What is the 52-week high for Histogen Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Histogen Inc 52 week high is $1.05 as of September 28, 2025.
What is the 52-week low for Histogen Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Histogen Inc 52 week low is $0.0501 as of September 28, 2025.
What is Histogen Inc stock price today?
Histogen Inc stock price today is $0.3511.
What was Histogen Inc stock price yesterday?
Histogen Inc stock price yesterday was $0.351.
What is the PE ratio of Histogen Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Histogen Inc’s P/E ratio is -0.12.
What is the Price-to-Book ratio of Histogen Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Histogen Inc P/B ratio is 0.2758.
What is Histogen Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Histogen Inc's EBITDA is 0.31.
What is the 50-day moving average of Histogen Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Histogen Inc 50-day moving average is $0.3842.
